Skip to main navigation

Teknova

Overview

Press Releases

Events & Presentations

SEC Filings

Stock Performance

Analyst Coverage

Leadership

Board of Directors

Committee Composition

Governance Overview

Compliance Hotline

Frequently Asked Questions

Contact Us

Email Alerts

News & Events

Press Releases

Events & Presentations

Financials

SEC Filings

Stock

Stock Performance

Analyst Coverage

Corporate Governance

Leadership

Board of Directors

Committee Composition

Governance Overview

Compliance Hotline

Resources

Frequently Asked Questions

Contact Us

Email Alerts

Press Releases

Year

September 27, 2023

Teknova Launches Latest Proprietary AAV-Tek™ Product and End-to-End Plasmid Workflow Solutions to Streamline Therapeutic Process Development

September 19, 2023

Teknova Announces Closing of $22.9 Million Concurrent Registered Direct Offering and Private Placement and Amends Credit Facility

September 18, 2023

Teknova Announces Up to $22.9 Million Concurrent Registered Direct Offering and Private Placement

August 16, 2023

Teknova Announces New Board Member, Martha J. Demski

August 10, 2023

Teknova Reports Second Quarter 2023 Financial Results

August 9, 2023

Teknova Announces Opening of New GMP-Certified Facility, Increasing Manufacturing Capacity for Custom, High-Quality Life Sciences Reagents

July 26, 2023

Teknova to Report Second Quarter 2023 Financial Results on August 10, 2023

July 20, 2023

Teknova and Sartorius BIA Separations Share Data Demonstrating Reliable and Scalable Approach for the Enhancement of AAV Full Capsid Enrichment with an Optimized AEX Platform

July 11, 2023

Teknova Expands Proprietary AAV-Tek™ Solutions Product Line to Deliver End-to-End Solutions for Gene Therapy Process Development

May 25, 2023

Teknova to Participate in Upcoming Investor Conference

Pagination

Current page 1
Page 2
Next page
Last page

Footer

LinkedIn Twitter

© 2023 Alpha Teknova, Inc. All rights reserved.